col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


80 Results       Page 1

 [1] 
Ovid: Arteriosclerosis Thrombosis and Vascular Biology
  original article Date Title Authors   All Authors
1 [GO] 2025―Sep―25 Dexamethasone Suppresses Endotheliopathy and Endothelial-Induced Coagulopathy in COVID-19 Aurélien Philippe, Romy Younan, Nicolas Gendron, Nicolas Peron, Xavier Loyer, Jeanne Rancic, et al. (+9)
2 [GO] 2025―Jun―23 Abstract We0034: Long COVID is Associated with Higher Incidences of Adverse Cardiovascular but not Renal Outcomes: A Global Retrospective Study Akash Pradeep, Srija Manchkanti, Sanjana Dayal
3 [GO] 2025―Jun―23 Abstract We0033: JAK/STAT Inhibition Modulates Endothelial Mixed Lineage Leukemia 1 (Kmt2a/MLL1) Induction and Immunothrombosis During SARS-CoV-2 Infection Nathaniel Parchment, Oscar Moreno, Kiran Kumar, Sriganesh Sharma, Sabrina Rocco, Catherine Luke, et al. (+3)
4 [GO] 2025―Jun―23 Abstract Th0026: Recombinant SARS-COV-2 Component Proteins Induce a Senescent Pulmonary Endothelial Cell Phenotype Colin Knight, Daniels Konja, Shuibang Wang, Ali Keshavarz, Gabriela Ferreyra, Daniel Chertow, et al. (+3)
5 [GO] 2025―Jun―23 Abstract We0035: Pulmonary Artery-on-a-Chip Model of Endothelial Senescence in COVID-19 Vasculopathy Isha Patel, Ali Keshavarz, Edward Dougherty, Keytam S. Awad, Shuibang Wang, Colin Knight, et al. (+9)
6 [GO] 2024―Dec―05 On-Treatment Change in d -Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19 Lana Wahid, Joshua Froess, Thomas L. Ortel, Ryan Zarychanski, Jeffrey S. Berger, Mary Cushman, et al. (+10)
7 [GO] 2024―Oct―09 COVID-19 Is a Coronary Artery Disease Risk Equivalent and Exhibits a Genetic Interaction With ABO Blood Type James R. Hilser, Neal J. Spencer, Kimia Afshari, Frank D. Gilliland, Howard Hu, Arjun Deb, et al. (+5)
8 [GO] 2024―Aug―21 Letter by Brambilla et al Regarding Article, “Monocyte-Mediated Thrombosis Linked to Circulating Tissue-Factor and Immune Paralysis in COVID-19” Marta Brambilla, Alessia Becchetti, Kevin Nallio, Marina Camera
9 [GO] 2024―Aug―21 Response by Goonewardena et al to Letter Regarding Article, “Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19” Sascha N. Goonewardena, Qinzhong Chen, Ashley M. Tate, Olga G. Grushko, Dilna Damodaran Puthiya Veettil, Pennelope K. Blakely, et al. (+3)
10 [GO] 2024―Aug―08 Innate Immune Dysregulations and Cross Talk in COVID-19: Novel Players in Atherogenesis Natalia Eberhardt, Chiara Giannarelli
11 [GO] 2024―Jul―24 Abstract 1095: Association Between Active Cancer And The Risk Of Thrombotic And Cardiovascular Outcomes In Patients With Covid-19 Bridget McGonagle, Christie M Greason, Darsiya Krishnathasan, Antoine Bejjani, Candrika Khairani, Nada Hamade, et al. (+34)
12 [GO] 2024―Jul―24 Abstract 3040: Quantitative Proteomic Analysis Of HDL Shows Apolipoprotein M (ApoM) As A Possible Marker For COVID-19 Mortality Douglas R Souza Junior, Amanda R Silva, Lívia R Fernandes, Giuseppe Palmisano, Graziella E Ronsein
13 [GO] 2024―Jul―24 Abstract 1068: Peak Gamma' Fibrinogen Levels Are Associated With Death In COVID-19 Patients Queen Revollido, Lydia Buzzard, Matthew Strnad, Akram Khan, William Messer, David H Farrell
14 [GO] 2024―Jul―24 Abstract 3110: Association Of Non-O Blood Group With Cardiovascular Outcomes Among Covid-19 Patients Nada Hamade, Hannah Leyva, Darsiya Krishnathasan, Sina Rashedi, Antoine Bejjani, Candrika D Khairani, et al. (+34)
15 [GO] 2024―Jul―24 Abstract 2119: Transcriptomic Profiling Reveals Therapeutic Potential Of Docosahexaenoic Acid For SARS Coronaviruses Infection Management Shiqi Huang, Carla G TAYLOR, Peter Zahradka
16 [GO] 2024―Jul―24 Abstract 112: Endothelial Mixed Lineage Leukemia 1 (kmt2a/MLL1) As A Central Mediator Of Immunothrombosis During SARS-CoV-2 Infection Nathaniel Parchment, Sriganesh Sharma, Kiran Kumar, Sabrina Rocco, Oscar Y Moreno, Catherine Luke, et al. (+3)
17 [GO] 2024―Jul―24 Abstract 2118: Inhibition of Poldip2 Protects Against SARS-CoV-2 Inflammation Ruinan Hu, Taylor White, Mirko Paiardini, Cynthia Derdeyn, Steven Bosinger, Bernard P Lassegue, et al. (+2)
18 [GO] 2024―Jul―11 Synergy Between NK Cells and Monocytes in Potentiating Cardiovascular Disease Risk in Severe COVID-19 Manuja Gunasena, Mario Alles, Yasasvi Wijewantha, Will Mulhern, Emily Bowman, Janelle Gabriel, et al. (+14)
19 [GO] 2024―Mar―21 Monocyte-Mediated Thrombosis Linked to Circulating Tissue Factor and Immune Paralysis in COVID-19 Sascha N. Goonewardena, Qinzhong Chen, Ashley M. Tate, Olga G. Grushko, Dilna Damodaran, Pennelope Blakely, et al. (+3)
20 [GO] 2024―Feb―21 Tissue Factor and COVID-19 Associated Thrombosis Nigel Mackman
21 [GO] 2023―Oct―02 Abstract 154: Crossroads Of Immunity And Coagulation: Protease Activity Of Complement Component C1s Inhibits Protein C Activation In Covid-19 Alicia S Eustes, Kathy H Nguyen, azaj ahmed, Steven R Lentz, Sanjana Dayal
22 [GO] 2023―Oct―02 Abstract 350: High-dimensional Analysis Of Circulating Blood Cells Reveals Distinct Granulocyte Activation And NETosis Profiles In COVID-19 Sirima Kraisin, Pier Andrée Penttila, Reena Chinnaraj, Cato Jacobs, Joost Wauters, Kimberly Martinod
23 [GO] 2023―Oct―02 Abstract 261: Tissue Factor Pathway Inhibitor Prolongs The Initiation Of Thrombin Generation And Is Associated With Acute Kidney Injury In Covid-19 Alicia S Eustes, Steven R Lentz, Sanjana Dayal
24 [GO] 2023―Oct―02 Abstract 625: Alteration Of Circulating Ace2-network Related Micrornas In Patients With Covid-19 Zofia Wicik, Disha Keshwani, Ceren Eyileten, Anna Nowak, Sérgio N Simões, David C Martins, et al. (+7)
25 [GO] 2023―Oct―02 Abstract 624: Racial Difference In Acute Myocardial Infarction-Mortality During Covid-19 Maan A Awad, Harshith Thyagaturu, Karthik Gonuguntla, Muchi Ditah D Chobufo, Sudarshan balla, Marcelino Mederos Liriano, Matthew J Santer
26 [GO] 2023―Oct―02 Abstract 420: In-hospital Statin Use Is Not Associated With Lower Mortality In Patients Hospitalized With Covid-19 Crystal L Yan, Beatriz Rivera Rodriguez, Sharon Andrade-Bucknor
27 [GO] 2023―Oct―02 Abstract 628: Molecular Mechanisms of Covid-19 in the Lungs and Heart: Insights from Spatial Transcriptomics Stefan Veizades, Emmanouil G Solomonidis, Ziwen Li, Rainha Passi, Bronwyn Berkeley, Katherine R Stewart, et al. (+10)
28 [GO] 2023―Oct―02 Abstract 262: A Novel Humanized ACE2 Mouse Model For Evaluating COVID-19 Infection In Cardiovascular Disease Cadence Lee, Chris S Mantsounga, Sheila Sharma, Rachel T Carley, Elizabeth Amelotte, Julia Pierce, et al. (+4)
29 [GO] 2023―Oct―02 Abstract 264: In-hospital Antiplatelet Use Is Associated With Decreased Thromboembolic Events In Covid-19 Patients Crystal L Yan, Beatriz Rivera Rodriguez, Sharon Andrade-Bucknor
30 [GO] 2023―Oct―02 Abstract 419: Liberation Of Soluble Urokinase Plasminogen Receptor (supar) Occurs In Response To Coronavirus Infection But Not To Influenza Virus Infection Sriganesh B Sharma, Kiran Kumar, Weisheng Wu, Salim S Hayek, Bethany B Moore, Andrea T Obi
31 [GO] 2023―Oct―02 Abstract 265: Coronavirus Infection Induced Interferon Signaling Promotes Atherosclerotic Plaque Vulnerability Hanming Zhang, Xinbo Zhang, Daniel Jovin, Jonathan Sun, Bal K Chaube, Enric Esplugues, et al. (+2)
32 [GO] 2023―Oct―02 Abstract 626: RNA Interference To Knock Down Endothelial Von Willebrand Factor Protects Against Endothelial Infection By SARS-CoV-2 Giulia Furini, Alessandro De Carli, Rossella Fonnesu, Pietro G Spezia, Mauro Pistello, Michele Lai, Vincenzo Lionetti
33 [GO] 2023―Oct―02 Abstract 280: Association Between Sars-cov-2 Infection And Abdominal Aortic Aneurysms (AAAs) Baohui Xu, Toru Ikezoe, Jia Guo, Gang Li, Makoto Samura, sihai zhao, Ronald L Dalman
34 [GO] 2023―Oct―02 Abstract 418: Sars-cov2 Infection Leads To Pulmonary Vascular Remodeling In Transgenic Mice Expressing Human ACE2 In Vascular Cells Angèle Frisdal, Serban Morosan, Christelle Enond, Stéphane Sylvain Marot, Anne-Geneviève Marcelin, Stéphane Hatem, Sophie Nadaud
35 [GO] 2023―Jun―29 Novel Tissue Factor Inhibition for Thromboprophylaxis in COVID-19: Primary Results of the ASPEN-COVID-19 Trial Connie N. Hess, Judith Hsia, Ian A. Carroll, Mark R. Nehler, Wolfram Ruf, David A. Morrow, et al. (+16)
36 [GO] 2023―Apr―26 Correction to: Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice
37 [GO] 2022―Nov―30 Abstract 395: Assessing Current Therapeutic Anticoagulation Strategies In Severely Obese Patients With Covid-19 Joseph You
38 [GO] 2022―Nov―30 Abstract 460: Covid-19 And Acute Limb Ischemia: Arterial Thromboemboli Composition And Architecture Max Wohlauer, Lauren Schmitt, Ahana Ghosh, Nicholas Govsyeyev, Donald Jacobs, Kirk Hansen
39 [GO] 2022―Nov―30 Abstract 461: Antiphospholipid Antibodies In Covid-19 Convalescent Plasma Wyatt Becicka, Gil Berreby, Jintao Wang, Jaideep Moitra, Sumith Panicker, Benjamin Tourdot, et al. (+6)
40 [GO] 2022―Nov―30 Abstract 113: Novel Tissue Factor Inhibition For Thromboprophylaxis In COVID-19: Primary Results Of The ASPEN-COVID-19 Phase 2b Randomized Trial Connie N Hess, Mark R Nehler, Judith A Hsia, Wolfram Ruf, David A Morrow, Jose Nicolau, et al. (+12)
41 [GO] 2022―Nov―30 Abstract 114: The Epigenetic Enzyme KMT2A/MLL1 Is A Driver Of Coronavirus Associated Coagulopathy Sriganesh B Sharma, William J Melvin, Christopher O Audu, Yogendra Kanthi, Jason S Knight, Nicole Rhoads, et al. (+7)
42 [GO] 2022―Nov―30 Abstract 111: Multiparametric Circulating Cardiovascular Biomarkers Elucidate A Molecular Signature Of Coronavirus Disease 2019 Mortality And Identify Vascular Barrier Stabilizing Therapies Dakota Gustafson, Michelle Ngai, Ruilin Wu, Huayun Hou, Clara Erice, Michael Wilson, et al. (+5)
43 [GO] 2022―Nov―30 Abstract 255: Immunohistochemical Analysis Of Sars-cov-2 Induced Microvascular Thrombosis Quinn S Navarro, Michael J Duryee, Ryan J Ruskamp, Geoffrey Thiele, Stanley J Radio, Daniel R Anderson
44 [GO] 2022―Nov―30 Abstract 256: Biomarker Shift In Convalescent Heart Patients Recovering From Sars-cov-2 Infection Ryan J Ruskamp, Michael J Duryee, Quinn S Navarro, Geoffrey Thiele, Daniel R Anderson
45 [GO] 2022―Nov―30 Abstract 112: Sars-cov-2 Infection Promotes Dyslipidemia And Non-alcoholic Steatohepatitis In Diet-induced Obese Golden Syrian Hamsters Francois Briand, Valentin Sencio, Thierry SULPICE, François Trottein
46 [GO] 2022―Jul―08 Thromboinflammation: From Atherosclerosis to COVID-19 Denisa D. Wagner, Lukas A. Heger
47 [GO] 2022―May―02 Abstract MP03: Histone-mediated Platelet Activation And Microvesicle-induced Thrombin Generation In COVID-19 Alicia S Eustes, Jagadish Swamy, melissa jensen, Katina M Wilson, Shibani M Kudchadkar, Usha Perepu, et al. (+3)
48 [GO] 2022―May―02 Abstract 109: Platelets Amplify Endotheliopathy In Covid-19 Tessa J Barrett, MacIntosh Cornwell, Khrystyna Myndzar, Christina Rolling, Yuhe Xia, Kamelia Drenkova, et al. (+18)
49 [GO] 2022―May―02 Abstract P124: Post Acute Infection Of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads To Systemic Inflammation And Podocyte Injury. Seshagiri Nandula, Sabyasachi Sen, Beda Brichacek, Rajesh Naidu Janapala
50 [GO] 2022―May―02 Abstract 111: Vein-Chip Is A New Experimental Model To Predict Pathophysiology Of SARS-CoV-2 Induced Thrombosis Navaneeth Krishna Rajeeva Pandian, John H Connor, John P Cooke, Abhishek Jain
51 [GO] 2022―May―02 Abstract MP43: Liposome-human ACE2 Complex As An Engineered Decoy To Abrogate SARS-CoV-2-induced Inflammatory Responses In Macrophages Sandro Satta, Zhaojie Meng, Rebecca Hernandaz, Susana Cavallero, Tong Zhou, Tzung K Hsiai, Changcheng Zhou
52 [GO] 2021―Sep―30 Circulating Lipids and COVID-19: Insights From Mendelian Randomization Michael G. Levin
53 [GO] 2021―Sep―09 Causal Associations Between Blood Lipids and COVID-19 Risk: A Two-Sample Mendelian Randomization Study Kun Zhang, Shan-Shan Dong, Yan Guo, Shi-Hao Tang, Hao Wu, Shi Yao, et al. (+6)
54 [GO] 2021―Sep―09 Interleukin-1RA Mitigates SARS-CoV-2-Induced Inflammatory Lung Vascular Leakage and Mortality in Humanized K18-hACE-2 Mice Shiqin Xiong, Lianghui Zhang, Justin M. Richner, Jake Class, Jalees Rehman, Asrar B. Malik
55 [GO] 2021―May―26 Correction to: Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19
56 [GO] 2021―May―26 Response by Mackman et al to Letter Regarding Article, “Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report” Nigel Mackman, Yohei Hisada, Steven P. Grover, Axel Rosell, Sebastian Havervall, Fien von Meijenfeldt, et al. (+3)
57 [GO] 2021―May―26 Letter by Brambilla et al Regarding Article, “Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report” Marta Brambilla, Paola Canzano, Alessia Becchetti, Elena Tremoli, Marina Camera
58 [GO] 2021―Apr―29 Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19 Carolin Langnau, Anne-Katrin Rohlfing, Sarah Gekeler, Manina Günter, Simone Pöschel, Álvaro Petersen-Uribe, et al. (+10)
59 [GO] 2021―Apr―21 Letter by Carmona et al Regarding Article, “Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: a National Population-Based Cohort Study” Adrien Carmona, Benjamin Marchandot, Kensuke Matsushita, Olivier Morel
60 [GO] 2021―Apr―01 Endothelial Injury in COVID-19 and Acute Infections Jerrold H. Levy, Toshiaki Iba, Elizabeth E. Gardiner
61 [GO] 2021―Feb―25 Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19 Annabelle Dupont, Antoine Rauch, Senna Staessens, Mouhamed Moussa, Mickael Rosa, Delphine Corseaux, et al. (+20)
62 [GO] 2021―Feb―24 Letter by Brambilla et al Regarding Article, “Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia” Marta Brambilla, Paola Canzano, Elena Tremoli, Marina Camera
63 [GO] 2021―Feb―04 Beneficial Effect of Statins in COVID-19-Related Outcomes Hae-Young Lee, Juhee Ahn, Juhong Park, Chang Kyung Kang, Sung-Ho Won, Dong Wook Kim, et al. (+7)
64 [GO] 2021―Jan―27 Neutrophil Extracellular Traps as Prognostic Markers in COVID-19 Anna S. Ondracek, Irene M. Lang
65 [GO] 2020―Dec―17 Journey to a Receptor for Advanced Glycation End Products Connection in Severe Acute Respiratory Syndrome Coronavirus 2 Infection Divya Roy, Ravichandran Ramasamy, Ann Marie Schmidt
66 [GO] 2020―Dec―03 Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19 Henry Ng, Sebastian Havervall, Axel Rosell, Katherina Aguilera, Kristel Parv, Fien A. von Meijenfeldt, et al. (+4)
67 [GO] 2020―Dec―03 Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality Axel Rosell, Sebastian Havervall, Fien von Meijenfeldt, Yohei Hisada, Katherina Aguilera, Steven P. Grover, et al. (+3)
68 [GO] 2020―Nov―16 COVID-19 and Sepsis Are Associated With Different Abnormalities in Plasma Procoagulant and Fibrinolytic Activity Emma G. Bouck, Frederik Denorme, Lori A. Holle, Elizabeth A. Middelton, Antoinette Blair, Bas de Laat, et al. (+5)
69 [GO] 2020―Oct―22 ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Serine Protease 2) Expression and Localization of SARS-CoV-2 Infection in the Human Heart Atsushi Sakamoto, Rika Kawakami, Kenji Kawai, Andrea Gianatti, Dario Pellegrini, Robert Kutys, et al. (+11)
70 [GO] 2020―Oct―21 Letter by Hamilton et al Regarding Article, “Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients” David O. Hamilton, Alicia A.C. Waite, Ingeborg D. Welters
71 [GO] 2020―Oct―14 Platelets Promote Thromboinflammation in SARS-CoV-2 Pneumonia Francesco Taus, Gianluca Salvagno, Stefania Canè, Cristiano Fava, Fulvia Mazzaferri, Elena Carrara, et al. (+14)
72 [GO] 2020―Sep―29 Incidence and Outcomes of Thrombotic Events in Symptomatic Patients With COVID-19 Ayman Elbadawi, Islam Y. Elgendy, Aditya Sahai, Rohan Bhandari, Meghann McCarthy, Marcelo Gomes, et al. (+4)
73 [GO] 2020―Sep―22 COVID-19 and Respiratory System Disorders Shari B. Brosnahan, Annemijn H. Jonkman, Matthias C. Kugler, John S. Munger, David A. Kaufman
74 [GO] 2020―Sep―10 COVID-19 in the Healthy Patient Population Diana Maria Ronderos Botero, Alaa Mabrouk Salem Omar, Haozhe Keith Sun, Nikhitha Mantri, Ked Fortuzi, Yongsub Choi, et al. (+4)
75 [GO] 2020―Aug―25 Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients With COVID-19 Jeffrey S. Berger, Dennis Kunichoff, Samrachana Adhikari, Tania Ahuja, Nancy Amoroso, Yindalon Aphinyaphongs, et al. (+13)
76 [GO] 2020―Aug―07 Endothelial Dysfunction and Thrombosis in Patients With COVID-19 Seigo Nagashima, Monalisa Castilho Mendes, Ana Paula Camargo Martins, Nícolas Henrique Borges, Thiago Mateus Godoy, Anna Flavia Ribeiro dos Santos Miggiolaro, et al. (+3)
77 [GO] 2020―Jul―30 Narrowing in on the True Rate of Venous Thromboembolism in Hospitalized Patients With COVID-19 Disease Deborah M. Siegal, Peter L. Gross
78 [GO] 2020―Jul―20 COVID-19 and the Heart and Vasculature Bernard S. Kadosh, Michael S. Garshick, Juan Gaztanaga, Kathryn J. Moore, Jonathan D. Newman, Michael Pillinger, et al. (+6)
79 [GO] 2020―Jul―13 Coagulation Abnormalities and Thrombosis in Patients Infected With SARS-CoV-2 and Other Pandemic Viruses Nigel Mackman, Silvio Antoniak, Alisa S. Wolberg, Raj Kasthuri, Nigel S. Key
80 [GO] 2020―Jul―06 Comparison of Venous Thromboembolism Risks Between COVID-19 Pneumonia and Community-Acquired Pneumonia Patients Fei Mei, Jiawei Fan, Jinhua Yuan, Zhenzhen Liang, Kewei Wang, Jianfeng Sun, et al. (+4)
 [1] 

80 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.005 sec